Brief: Oasmia Says Xmena Patent Approved In India And Soon In Australia
Oct 26 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA SECURES IMPORTANT IP RIGHTS
* XMENA PATENT APPROVED IN INDIA AND SOON IN AUSTRALIA
* REGISTRATIONS FOR APEALEA APPROVED IN SWITZERLAND, ISRAEL,
SOUTH
AFRICA, MALAYSIA AND INDONESIA DURING 2020
Source text for Eikon: ID:nMFN4Tbx2t
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO